Resistance to obinutuzumab-induced antibody-dependent cellular cytotoxicity caused by abnormal Fas signaling is overcome by combination therapies

Natsumi Kawasaki(The University of Tokyo), Yasushi Yoshimura
Molecular Biology Reports
February 26, 2022
Cited by 11


Related Papers